Hemply Balance Holding
0.03 SEK
Less than 1K followers
HMPLY
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Hemply Balance Holding
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | 2.3 | 4.7 | 2.1 | 1.2 | 0.8 |
| growth-% | 102.7 % | -55.0 % | -44.8 % | -27.8 % | |
| EBITDA | -12.0 | -6.0 | -3.6 | -0.6 | -0.5 |
| EBIT | -25.1 | -6.6 | -3.6 | -0.6 | -0.5 |
| Profit before taxes | -25.1 | -9.9 | -3.6 | -0.6 | -0.5 |
| Net income | -25.1 | -9.9 | -3.6 | -0.6 | -0.5 |
| EPS | -3.69 | -1.28 | -0.32 | -0.01 | 0.00 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Profitability and return on capital
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| EBITDA-% | -521.4 % | -129.3 % | -170.5 % | -52.6 % | -56.1 % |
| EBIT-% | -1,088.7 % | -141.3 % | -170.5 % | -53.4 % | -56.4 % |
| ROE | -744.7 % | -380.0 % | -973.0 % | -52.1 % | -68.4 % |
| ROI | -457.8 % | -289.7 % | -230.8 % | -44.9 % | -50.7 % |